BF Biosciences Limited (PSX:BFBIO)

Market Cap	16.48B
Revenue (ttm)	4.96B
Net Income (ttm)	391.70M
Shares Out	88.33M
EPS (ttm)	5.24
PE Ratio	35.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,179,070
Average Volume	2,240,927
Open	180.90
Previous Close	180.08
Day's Range	179.00 - 192.45
52-Week Range	76.06 - 253.97
Beta	n/a
RSI	65.55
Earnings Date	May 29, 2025

About BF Biosciences

BF Biosciences Limited, a diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products. It offers a range of products in the areas of nephrology, cardiology, gastroenterology, diabetes, oncology, anti-viral, and hepatology. The company was incorporated in 2006 and is headquartered in Raiwind, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited.

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Country: Pakistan
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: BFBIO

Financial Performance

In 2024, BF Biosciences's revenue was 3.66 billion, an increase of 102.19% compared to the previous year's 1.81 billion. Earnings were 385.41 million, an increase of 158.57%.